Status:
RECRUITING
Home-Based Exercise Tele-Rehabilitation After COVID-19
Lead Sponsor:
VA Office of Research and Development
Collaborating Sponsors:
Baltimore VA Medical Center
Salem Veterans Affairs Medical Center
Conditions:
Post SARS-CoV2 (COVID-19)
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
The Coronavirus Disease 2019 (COVID-19) pandemic has resulted in catastrophic infections and fatalities across the nation. Many older Veterans with comorbidities are especially vulnerable to complicat...
Detailed Description
There is an urgent need to understand the lasting impact of COVID-19 on the cardiopulmonary system to improve physical function and prevent long-lasting disability. Pertinent knowledge gaps regarding ...
Eligibility Criteria
Inclusion
- Veteran
- documented COVID-19 \> 90 days ago
- diagnosis of 2 of following conditions: hypertension, diabetes, cardiovascular disease, chronic kidney disease, chronic obstructive pulmonary disease OR 1 condition and BMI \> 30 kg/m2
Exclusion
- myocardial infarction (within 3 months)
- exertional or unstable angina (chest pain that limits activity)
- severe congestive heart failure (EF \< 20% in last year or NYHA Classification III or IV)
- uncontrolled hypertension (SBP \>180 \&/or DBP \> 110 mm Hg at screening)
- screening EKG with ischemia, complex arrhythmia, or high-grade block (per Minnesota Code)
- poorly controlled diabetes mellitus (FBS\>200 mg/dl, RBS \> 299 mg/dl, or HbA1C \> 10)
- treatment for cancer except skin cancer (within 3 months)
- peripheral vascular disease with claudication
- severe arthritis limiting ambulation
- neurologic disease limiting ambulation (weakness requiring assist device; severe neuropathy)
- end stage liver disease (decompensated liver disease)
- End stage renal failure (dialysis)
- severe pulmonary disease (home O2, admission for dyspnea or pneumonia within 1 month)
- high fall risk (history of falls, bone fracture)
- dementia (based on Evaluation to Consent)
- signs or symptoms of any medical comorbidity that would preclude exercise testing or training
- exercises on routine basis (structured aerobic exercise \> 3 time per week)
Key Trial Info
Start Date :
June 29 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2028
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05425264
Start Date
June 29 2023
End Date
January 30 2028
Last Update
November 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, United States, 21201